Patients with hypertension and diabetes had a higher prevalence of replacement myocardial fibrosis compared to those with hypertension alone (28% vs 16%, P<0.001).
Observational (n=605)
Does comorbid diabetes increase myocardial fibrosis and alter proteomic signatures in patients with hypertension?
The addition of diabetes to hypertension is associated with worse adverse cardiac remodeling, increased myocardial fibrosis, and distinct inflammatory proteomic signatures compared to hypertension alone.
Absolute Event Rate: 28% vs 16%
p-value: p=<0.001
BACKGROUND: Compared with patients with hypertension only, those with hypertension and diabetes (HTN/DM) have worse prognosis. We aimed to characterize morphological differences between hypertension and HTN/DM using cardiovascular magnetic resonance; and compare differentially expressed proteins associated with myocardial fibrosis using high throughput multiplex assays. METHODS: Asymptomatic patients underwent cardiovascular magnetic resonance: 438 patients with hypertension (60±8 years; 59% males) and 167 age- and sex-matched patients with HTN/DM (60±10 years; 64% males). Replacement myocardial fibrosis was defined as nonischemic late gadolinium enhancement on cardiovascular magnetic resonance. Extracellular volume fraction was used as a marker of diffuse myocardial fibrosis. A total of 184 serum proteins (Olink Target Cardiovascular Disease II and III panels) were measured to identify unique signatures associated with myocardial fibrosis in all patients. RESULTS: Despite similar left ventricular mass ( P =0.344) and systolic blood pressure ( P =0.086), patients with HTN/DM had increased concentricity and worse multidirectional strain ( P <0.001 for comparison of all strain measures) compared to hypertension only. Replacement myocardial fibrosis was present in 28% of patients with HTN/DM compared to 16% of those with hypertension ( P <0.001). NT-proBNP (N-terminal pro-B-type natriuretic peptide) was the only protein differentially upregulated in hypertension patients with replacement myocardial fibrosis and independently associated with extracellular volume. In patients with HTN/DM, GDF-15 (growth differentiation factor 15) was independently associated with replacement myocardial fibrosis and extracellular volume. Ingenuity Pathway Analysis demonstrated a strong association between increased inflammatory response/immune cell trafficking and myocardial fibrosis in patients with HTN/DM. CONCLUSIONS: Adverse cardiac remodeling was observed in patients with HTN/DM. The novel proteomic signatures and associated biological activities of increased immune and inflammatory response may partly explain these observations.
Pua et al. (Sat,) conducted a observational in Hypertension with or without diabetes (n=605). Hypertension and diabetes (HTN/DM) vs. Hypertension only was evaluated on Replacement myocardial fibrosis (p=<0.001). Patients with hypertension and diabetes had a higher prevalence of replacement myocardial fibrosis compared to those with hypertension alone (28% vs 16%, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: